TCL Archive In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit December 18, 2009
TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive NCI Drops Breast Screening Guidelines, Issues “Summary Of Scientific Fact” December 10, 1993
TCL Archive Field Studies Chief Leave For Job with Upton; Sibal Named DCCP Acting Deputy October 27, 1978
TCL Archive In Brief: Twenty-Nine Percent Of Approved Organ Systems Applications Funded In February, May Cycles November 4, 1983
TCL Archive Clinical Societies, Patient Groups Need New Alliance, Glick Proposes to ASCO May 24, 1996
